⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 18, 2020Open Access

Methods and Compositions Related to T-Cell Activity

Yan Zheng Zha Yuanyuan Robbert M. Spaapen Thomas F. Gajewski

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to explore methods to enhance the activity of anergic T-cells in cancer patients.
Investigated methods and compositions that could stimulate T-cell activity.
Focused on interventions for anergic T-cells in the context of cancer therapy.
Enhanced T-cell activity observed in patients receiving specific treatments for anergy.
Potential therapeutic applications identified for improving immune responses in cancer.

Implication

Examines methods to enhance T-cell activity in cancer patients, suggesting therapeutic potential.

Abstract

Embodiments concern methods and composition related to anergic T-cells in patients, such as cancer patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zheng et al. (2020) studied this question.

synapsesocial.com/papers/6a2117bfd499ed480b17098d https://doi.org/10.6082/0rf2g-bp857

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Methods and Compositions Related to T-Cell ActivityOriginal Research · 2020
2Methods and compositions related to T-cell activityIn Vitro Study · 2014
3Methods and compositions related to T-cell activityIn Vitro Study · 2014
4Adoptive cell therapy for cancer: combination strategies and biomarkers2025 · 10 citations
5Overview of T-Cell Therapy: An Enormous Breakthrough in the Fight against Cancer2024

T cell receptor-directed antibody-drug conjugates for the treatment of T cell-derived cancers2024
Broadening anticancer spectrum by preprocessing and treatment of T- lymphocytes expressed FcγRI and monoclonal antibodies for refractory cancers2024
Abstract 723: Reduction of immunosuppressive function of regulatory T cells enhances antigen-specific T cell mediated cytotoxicity against tumor cells2024